Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure.

[1]  S. Frank,et al.  Definitive radiation therapy for squamous cell carcinoma of the vagina. , 2005, International journal of radiation oncology, biology, physics.

[2]  C. N. Coleman,et al.  CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. , 2003, Seminars in radiation oncology.

[3]  H. Menck,et al.  The national cancer data base report on cancer of the vagina , 1998, Cancer.

[4]  L. Delclos,et al.  Definitive radiotherapy for carcinoma of the vagina: outcome and prognostic factors. , 1996, International journal of radiation oncology, biology, physics.

[5]  A. Herbst,et al.  Clear cell adenocarcinoma of the vagina and cervix secondary to intrauterine exposure to diethylstilbestrol. , 1990, Seminars in surgical oncology.

[6]  A. Herbst,et al.  An evaluation of stage II vaginal clear cell adenocarcinoma according to substages. , 1988, Gynecologic oncology.

[7]  L. Delclos,et al.  Primary squamous cell carcinoma of the vagina treated by radiotherapy: a failures analysis--the M. D. Anderson Hospital experience 1955-1982. , 1988, International journal of radiation oncology, biology, physics.

[8]  A. Herbst,et al.  Local therapy in stage I clear cell adenocarcinoma of the vagina , 1987, Cancer.

[9]  A. Herbst,et al.  Clear cell adenocarcinoma and the current status of DES‐exposed females , 1981, Cancer.

[10]  A. Herbst,et al.  Epidemiology of vaginal adenosis and adenocarcinoma associated with exposure to stilbestrol in utero , 1977, Cancer.

[11]  A. Herbst,et al.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women. , 1971, The New England journal of medicine.